Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy.
This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce.
Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C..
Price and Volume | |
---|---|
Volume | |
Ten Day Average Volume | 3.7M |
Three Month Average Volume | 121.5M |
High Low | |
Fifty-Two Week High | 99.6199 USD |
Fifty-Two Week Low | 36.17 USD |
Fifty-Two Week High Date | 14 Mar 2024 |
Fifty-Two Week Low Date | 08 Aug 2024 |
Price and Volume | |
Current Price | 38.03 USD |
Beta | 2 |
Relative Price Change | |
Four Week Relative Price Change | -15.72% |
Thirteen Week Relative Price Change | -55.57% |
Twenty-Six Week Relative Price Change | -56.37% |
Fifty-Two Week Relative Price Change | -53.56% |
Year-to-Date Relative Price Change | -41.10% |
Price Change | |
One Day Price Change | 1.06% |
Thirteen Week Price Change | -52.45% |
Twenty-Six Week Price Change | -52.02% |
Five Day Price Change | -3.82% |
Fifty-Two Week Price Change | -41.80% |
Year-to-Date Price Change | -30.25% |
Month-to-Date Price Change | -18.79% |
Per Share Data | |
---|---|
Book Value | |
Book Value Per Share (Last Fiscal Year) | 4.69623 USD |
Book Value Per Share (Most Recent Quarter) | 5.31507 USD |
Tangible Book Value Per Share (Last Fiscal Year) | 4.58272 USD |
Tangible Book Value Per Share (Most Recent Quarter) | 5.20699 USD |
EBITD | |
EBITD Per Share (Trailing Twelve Months) | 1.46003 USD |
Revenue | |
Revenue Per Share (Last Fiscal Year) | 5.56209 USD |
Revenue Per Share (Trailing Twelve Months) | 6.27591 USD |
Dividend | |
Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
Dividend Per Share (Trailing Twelve Months) | 0 USD |
Dividend Per Share (5 Year) | -99999.99 USD |
Earnings Per Share | |
Excluding Extraordinary Items (Last Fiscal Year) | 0.76801 USD |
Excluding Extraordinary Items (Trailing Twelve Months) | 1.01559 USD |
Normalized (Last Fiscal Year) | 0.79393 USD |
Basic Excluding Extraordinary Items (Last Fiscal Year) | 0.78858 USD |
Basic Excluding Extraordinary Items (Trailing Twelve Months) | 1.03851 USD |
Including Extraordinary Items (Last Fiscal Year) | 0.76801 USD |
Including Extraordinary Items (Trailing Twelve Months) | 1.01559 USD |
Cash | |
Cash Per Share (Last Fiscal Year) | 3.26153 USD |
Cash Per Share (Most Recent Quarter) | 3.87072 USD |
Cash Flow Per Share (Last Fiscal Year) | 0.85483 USD |
Cash Flow Per Share (Trailing Twelve Months) | 1.13223 USD |
Free Cash Flow Per Share (Trailing Twelve Months) | 0.92014 USD |
Margins | |
---|---|
Cash Flow Revenue | |
Cash Flow Revenue (5 Year) | 4 |
Cash Flow Revenue (Trailing Twelve Months) | 15 |
Pretax Margin | |
Pretax Margin (Trailing Twelve Months) | 24.81% |
Pretax Margin (Last Fiscal Year) | 22.14% |
Pretax Margin (5 Year) | 6.17% |
Gross Margin | |
Gross Margin (Last Fiscal Year) | 48.04% |
Gross Margin (Trailing Twelve Months) | 50.45% |
Gross Margin (5 Year) | 45.13% |
Operating Margin | |
Operating Margin (Last Fiscal Year) | 20.21% |
Operating Margin (Trailing Twelve Months) | 22.42% |
Operating Margin (5 Year) | 4.46% |
Net Profit Margin | |
Net Profit Margin (Last Fiscal Year) | 17.21% |
Net Profit Margin (Trailing Twelve Months) | 19.58% |
Net Profit Margin (5 Year) | 2.49% |
Growth | |
---|---|
Book Value | |
Book Value Per Share (5 Year) | 132.57% |
Tangible Book Value (5 Year) | 145.95% |
Free Operating Cash Flow | |
Free Operating Cash Flow (5 Year) | -99,999.99% |
Revenue | |
Revenue Change MRQ vs 1 Year Ago | 23.35% |
Revenue Growth (3 Year) | 90.45% |
Revenue Change (Trailing Twelve Months) | 56.50% |
Revenue Per Share Growth | 73.84% |
Revenue Growth (5 Year) | 116.03% |
Capital Spending Debt | |
Capital Spending (5 Year) | 175.21% |
Total Debt (5 Year) | -49.87% |
Dividends | |
Dividend Growth (3 Year) | -99,999.99% |
Earnings Per Share | |
EPS Change MRQ vs 1 Year Ago | 62.99% |
EPS Change (Trailing Twelve Months) | 258.87% |
EPS Growth (3 Year) | -99,999.99% |
EPS Growth (5 Year) | 171.99% |
EBITDA | |
EBITDA (5 Year) | -99,999.99% |
EBITDA (5 Year Interim) | -99,999.99% |
Net Profit Margin | |
Net Profit Margin Growth (5 Year) | -99,999.99% |
Valuation | |
---|---|
Total Price to Book | |
Price to Tangible Book (Last Fiscal Year) | 8 |
Price to Tangible Book (Most Recent Quarter) | 7 |
Price to Free Cash Flow | |
Price to Free Cash Per Share (Last Fiscal Year) | 92 |
Price to Free Cash Per Share (Trailing Twelve Months) | 41 |
Net Debt | |
Net Debt (Most Recent Quarter) | -902,921,000 |
Net Debt (Last Fiscal Year) | -755,729,000 |
Price to Sales | |
Price to Sales (Last Fiscal Year) | 7 |
Price to Sales (Trailing Twelve Months) | 6 |
Price to Earnings | |
PE Excluding Extraordinary Items (Last Fiscal Year) | 37 |
PE Normalized (Last Fiscal Year) | 48 |
PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 55 |
PE Excluding Extraordinary Items High (Trailing Twelve Months) | 1.5K |
PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 21 |
PE Including Extraordinary Items (Trailing Twelve Months) | 37 |
Dividends | |
Dividend Yield (5 Year) | -99,999.99% |
Dividend Yield | -99,999.99% |
Current Dividend Yield | 0.00% |
Price to Book | |
Price to Book (Last Fiscal Year) | 33 |
Price to Book (Most Recent Quarter) | 21 |
Financial Strength | |
---|---|
Debt to Equity | |
Long Term Debt to Equity (Last Fiscal Year) | 0 |
Long Term Debt to Equity (Most Recent Quarter) | 0 |
Payout Ratio | |
Payout Ratio (Last Fiscal Year) | 0.00% |
Payout Ratio (Trailing Twelve Months) | 0.00% |
Quick Ratio | |
Quick Ratio (Last Fiscal Year) | 4 |
Quick Ratio (Most Recent Quarter) | 4 |
Enterprise Value | |
Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 57 |
Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 40 |
Current Ratio | |
Current Ratio (Last Fiscal Year) | 4 |
Current Ratio (Most Recent Quarter) | 4 |
Free Cash Flow | |
Free Cash Flow (Last Fiscal Year) | 96.3M |
Free Cash Flow (Trailing Twelve Months) | 218.4M |
Net Interest Coverage | |
Net Interest Coverage (Last Fiscal Year) | -100,000 |
Net Interest Coverage (Trailing Twelve Months) | -100,000 |
Total Debt to Equity | |
Total Debt to Equity (Last Fiscal Year) | 0 |
Total Debt to Equity (Most Recent Quarter) | 0 |
Management Effectiveness | |
---|---|
Return on Assets | |
Return on Assets (Last Fiscal Year) | 16.44% |
Return on Assets (Trailing Twelve Months) | 18.71% |
Return on Assets (5 Year) | 2.44% |
Return on Equity | |
Return on Equity (Last Fiscal Year) | 119.68% |
Return on Equity (Trailing Twelve Months) | 88.19% |
Return on Equity (5 Year) | 1.00% |
Return on Investment | |
Return on Investment (Last Fiscal Year) | 19.55% |
Return on Investment (Trailing Twelve Months) | 23.00% |
Return on Investment (5 Year) | 2.96% |